No Data
Cutting-Edge Cancer Therapies Lead the Way Into a Transformative Year
Elevation Oncology Advances EO-3021 Trials to Target Advanced Gastric and GEJ Cancers With Improved Care
Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
William Blair Initiates Coverage On Elevation Oncology With Outperform Rating
William Blair Initiates Elevation Oncology(ELEV.US) With Buy Rating
Las Pride : and how about Split under the new rules, maybe?